Guillain-Barre syndrome associated with rocky mountain spotted fever: Case report and review

Clinical Infectious Diseases

Volumn 22, Issue 6, 1996, Pages 1090-1091

  Toerner, Joseph G ^a,b   Kumar, Princy N ^a   Garagusi, Vincent F ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXYCYCLINE; ACICLOVIR; ANTIINFECTIVE AGENT; METRONIDAZOLE;

ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CORRELATION FUNCTION; DISEASE ASSOCIATION; FEVER; GUILLAIN BARRE SYNDROME; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NERVE CONDUCTION; PRIORITY JOURNAL; RASH; RICKETTSIA CONORII; ROCKY MOUNTAIN SPOTTED FEVER; DRUG COMBINATION; MIDDLE AGED; POLYRADICULONEUROPATHY;

ACYCLOVIR; ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; POLYRADICULONEUROPATHY; ROCKY MOUNTAIN SPOTTED FEVER;

EID: 0029659018     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/22.6.1090     Document Type: Article

References (17)

1. Centers for Disease Control. Rocky Mountain spotted fever - United States, 1990. MMWR Morb Mortal Wkly Rep 1991;40:451-9.
2. Spach DH, Liles WC, Campbell GL, Quick RE, Anderson DE, Fritsche TR. Tick-borne diseases in the United States. N Engl J Med 1993;329:936-47.
3. Miller JQ, Price TR. The nervous system in Rocky Mountain spotted fever. Neurology 1972;22:561-6.
4. Ropper AH. The Guillain-Barre syndrome. N Engl J Med 1992;326:1130-6.
5. Kaplan JE, Schonberger LB, Hurwitz ES, Katona P. Guillain-Barre syndrome in the United States, 1978-1981: additional observations from the National Surveillance System. Neurology 1983;33:633-7.
6. Bonduelle M, Giroud P, Lormeau G, Acar J, Zalzal P. Polyradiculoneuritis with hyperalbuminorachitis and pleocytosis after insect bites. Positive reaction for Rickettsia conorii. Rev Neurol (Paris) 1968;119:244-7.
7. Rosenblum MJ, Masland RL, Harrell GT. Residual effects of rickettsial disease on the central nervous system: results of neurologic examinations and electroencephalograms following Rocky Mountain spotted fever. Arch Intern Med 1952;90:444-55.
8. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain spotted fever: a clinical dilemma. Curr Clin Top Infect Dis 1981;2:89-108.
9. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis 1984;150:480-8.
10. Kirk JL, Fine DF, Sexton DJ, Muchmore HG. Rocky Mountain spotted fever. A clinical review based on 48 confirmed cases, 1943-1986. Medicine (Baltimore) 1990;69:35-45.
11. Archibald LK, Sexton DJ. Long-term sequelae of Rocky Mountain spotted fever. Clin Infect Dis 1995;20:1122-5.
12. Steinfeld HJ, Silverstein J, Weisburger W, Rattner F. Deafness associated with Rocky Mountain spotted fever. Md Med J 1988;37:287-8.
13. Walker DH. Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis 1995;20:1111-7.
14. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis 1995;20:1118-21.
15. Gorman RJ, Snead OC. Tick paralysis in three children: the diversity of neurologic presentations. Clin Pediatr (Phila) 1978;17:249-51.
16. Feasby TE. Inflammatory-demyelinating polyneuropathies. Neurol Clin 1992;10:651-69.
17. Mishu B, Ilyas AA, Koski CL, et al. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barre syndrome. Ann Intern Med 1993;118:947-53.